Company Filing History:
Years Active: 2006-2025
Title: Claire Louise Russell: Innovator in Alzheimer's Disease Research
Introduction
Claire Louise Russell is a prominent inventor based in London, GB. She has made significant contributions to the field of Alzheimer's disease research, holding a total of 3 patents. Her work focuses on identifying biomarkers that can aid in the diagnosis and treatment of neurocognitive disorders.
Latest Patents
One of her latest patents involves biomolecules associated with Alzheimer's disease. This invention relates to panels of biomarkers, including proteins phosphatase 1 regulatory subunit 14A and/or 2',3'-cyclic-nucleotide 3'-phosphodiesterase and/or phosphorylated tau or fragments thereof. These biomarkers are crucial for diagnosing, staging, treating, and assessing the response to treatment for neurocognitive disorders characterized by tau toxicity, particularly Alzheimer's disease. The invention demonstrates that these biomarkers are elevated in the brains of subjects with advanced stages of the disorder and are regulated in the cerebrospinal fluid of Alzheimer's disease subjects compared to cognitively affected non-Alzheimer's controls.
Another significant patent focuses on materials and methods for diagnosing and treating Alzheimer's disease. Given the increasing prevalence of Alzheimer's disease among aging adults, the need for effective diagnostic tools and treatments is urgent. This patent identifies a panel of biomarkers in cerebrospinal fluid that can diagnose, stage, and determine the likelihood of developing Alzheimer's disease, particularly by using microglia activation as an early event in the disease's onset.
Career Highlights
Claire has worked with notable organizations, including Electrophoretics Limited and the University of California. Her career is marked by a commitment to advancing the understanding and treatment of Alzheimer's disease through innovative research.
Collaborations
She has collaborated with esteemed colleagues such as Ian Hugo Pike and Malcolm Andrew Ward, contributing to the collective effort in Alzheimer's research.
Conclusion
Claire Louise Russell's innovative work in Alzheimer's disease research highlights her dedication to improving diagnostic and treatment methods for neurocognitive disorders. Her contributions are vital in the ongoing battle against this prevalent condition.